GPP
Great Point Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,955,762
| Closed | -$48.5M | – | 27 |
|
|
2019
Q1 | $48.5M | Sell |
5,955,762
-1,666,494
| -22% | -$13.6M | 4.8% | 9 |
|
|
2018
Q4 | $61.5M | Sell |
7,622,256
-356,019
| -4% | -$2.87M | 7.77% | 1 |
|
|
2018
Q3 | $60.9M | Buy |
7,978,275
+500,000
| +7% | +$3.81M | 9.49% | 1 |
|
|
2018
Q2 | $42.9M | Hold |
7,478,275
| – | – | 5.94% | 4 |
|
|
2018
Q1 | $35.7M | Buy |
7,478,275
+2,726,392
| +57% | +$13M | 5.3% | 7 |
|
|
2017
Q4 | $23.3M | Buy |
4,751,883
+3,114,551
| +190% | +$15.3M | 3.98% | 9 |
|
|
2017
Q3 | $8.58M | Buy |
+1,637,332
| New | +$8.58M | 1.67% | 18 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 35 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 33 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 36 |
|